Mandate

Vinge advises eEducation Albert AB (publ) in connection with the listing on Nasdaq First North Growth Market6 October 2021

Vinge has advised eEducation Albert AB (publ) (”Albert”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 21 September 2021 and the first day of trading occurred on 1 October 2021.

The offer in connection with the listing covered approximately 4 700 000 newly issued shares as well as an oversubscription option for a further total amount of approximately 700 000 shares. The shares were offered at a price of SEK 49 per share, which entails that the offer (in conjunction with full utilization of the oversubscription option) amounted to approximately SEK 264 million. The price corresponds to a market value for the company of approximately SEK 600 million prior to the implementation of the offer.

Albert, which was founded in 2015 and has its registered office in Gothenburg, is an app‑based educational platform for children in the age intervals between 3 and 16 and offers EdTech services on a subscription basis. Since Albert was founded, the company has helped more than 275 000 families with their children’s education.

Vinge’s team primarily consisted of Wibeke SorlingEdin AgicLinus AdolfssonHanna Jansson (Capital Markets and Public M&A), Anna Backman (Employment), Alexander LindbergAnna Högsten (IP/IT), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024